Home › Overactive Bladder › NCT04527445
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Recruiting
Reduction in Fluoroscopy Radiation Exposure During Lead Implantation for Sacral Neuromodulation: A Randomized Prospective Study
Who can join
Ages 18 to 89 · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence. Exclusion Criteria: * neurogenic bladder, BMI \>40, or peripheral neuropathy.
About the study
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
What is being tested
- Reduced radiation fluoroscopy (procedure)
- Conventional fluoroscopy (procedure)
Sponsor: Loma Linda University · Participants: 44 · Started: 2026-06
Contact the study team
- Forrest Jellison, MD · Phone: 909 558-2830
Official record on ClinicalTrials.gov — NCT04527445
Locations in the U.S.
| California | Loma Linda University Health, Loma Linda |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.